Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
The three-drug combination cured most people who had experienced previous treatment failure.
Two thirds of people who currently use drugs completed treatment, and most of those were cured.
Mavyret was associated with the most improvement in post-traumatic stress disorder symptoms.
Pairing HCV testing and treatment eliminates the need to navigate the medical system.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
People who received a shortened course of antiviral therapy were less likely to be cured.
The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.
After inmates filed a class action lawsuit, Nevada agreed to treat all prisoners living with hepatitis C.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
The drug can quickly reverse opioid-driven overdoses.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.